Clinical nutrition is nutrition method of patients in health care industry. Clinical nutrition method includes providing healthy nutrition as well as other factors to the patients in hospitals. It also mainly includes the scientific fields of dietetics and nutrition. Clinical nutrition products help to keep a strong energy balance in patients and also provide sufficient amounts various other nutrients such as vitamins, protein and minerals. The report provides analysis of global clinical nutrition market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global clinical nutrition market is expected to grow at significant CAGR around 8.5% throughout the forecast period and reach around US$ 87 billion by 2026.
Growing number of people suffering from chronic diseases such as diabetes and cancer, growing demand for better and accurate diagnostic procedures, growth in the obese population, rising awareness towards the health related concerns, enhanced healthcare system, various research and development activities, and initiatives taken by favourable governments are some of the key factors that are fueling the clinical nutrition market growth across the globe. Rising occurrences of various chronic diseases such as diabetes, cancer and various initiatives taken by favourable governments are some of the fundamental factors driving the global clinical nutrition market growth. Growing prevalence of chronic diseases and lack of nutrients are anticipated to increase the growth of clinical nutrition prescriptions and also create immense opportunities for the global clinical nutrition market over the forecast period. Ever increasing obese population owing to the unhealthy nutritional habits and lack of physical activities are expected to further spur the overall market growth. A large number of aged people suffer from various digestive and appetite problems, and this needs nutrients supply through enteral or parenteral route, thereby, boosting the market growth. Rising number of pre-mature babies across the globe is driving the overall clinical nutrition market growth. Furthermore, rapidly increasing occurrences of various diseases along with the growing awareness amongst the patients is the key factor that positively impacting the growth of the segment. The increasing disposable income, growing urbanization and growth in the number of working mothers are some of the other factors projected to boost the adoption of child clinical nutrition methods throughout the forecast period. Development of healthcare infrastructure with the rising expenditure is expected to boost the demand for the various clinical nutrition products. However, lack of awareness towards clinical nutrition as well as stringent government regulations are some of the factors that may hinder the global clinical nutrition market growth.
Clinical Nutrition Market by Product
Clinical Nutrition Market by Consumer
Global Clinical Nutrition Market, by Geography
The market research study on “Clinical Nutrition Market (Clinical Nutrition Market by Product: Infant Nutrition [Milk based, Soy based, Organic formulas, Others], Enteral Nutrition [Standard composition, Disease specific composition], Parenteral Nutrition [Amino Acids, Fats, Carbohydrates]; Clinical Nutrition Market by Consumer: Child, Adult) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers detailed insights on global clinical nutrition market segments with market dynamics and their impact. The report provides insights on global clinical nutrition market by product, consumer and major geographic regions. The report also covers basic technology development policies.
The global clinical nutrition market is characterized by the presence of experienced and established players. Some of the key players include Nestle Nutrition, Lonza Ltd, Hospira Inc., Mead Johnson & Company, Kendall, Gentiva Health Services Inc., Abbott Laboratories Inc., H. J. Heinz Company, Ajinomoto Co. Inc., Baxter International Inc., American Home Patient Inc., Hero Nutritionals Inc., B. Braun Melsungen AG, and Fresenius Kabi.
Introduction According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026. TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to preve
Introduction According to Acumen Research and Consulting, the global Spatial Genomics & Transcriptomics market is expected to grow at noteworthy CAGR around 8.7 % throughout the forecast period and reach around US$ 270 million by 2026. Spacious genomics&transcriptomy enables researchers to see not just what is in a cell, but how cells are organized in re
Introduction According to Acumen Research and Consulting, the global scleroderma therapeutics market is forecasted to grow at striking CAGR around 6.4% over the forecast time frame and reach around US$ 3.8 billion by 2026. It is an autoimmune rheumatic condition which causes the skin and connective tissues to get chronically hardened and tightened. However, it i
Introduction According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026. Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For m
Introduction According to Acumen Research and Consulting, the global oral irrigator market value is expected to reach around US$ 1 billion by 2026 growing at CAGR around 3.6% over the forecast time frame 2019 to 2026. The device used to remove plaque and debris from between teeth is dental water or oral water irrigation. This method is carried out with a pulse w
Introduction According to Acumen Research and Consulting, the global Irritable Bowel Syndrome Treatment market is expected to grow at noteworthy CAGR around 9.8 % throughout the forecast period and reach around US$ 3.4 billion by 2026. IBS is a gastrointestinal functional disorder of the intestine that is characterized by contractions of the colon muscle. The bi